Centessa Pharmaceuticals plc

NASDAQ:CNTA

11.92 (USD) • At close June 6, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -26.135-111.329-42.566-43.816-38.046-37.157-38.648-24.886-50.714-43.173-53.875-64.661-54.498-60.911-39.975-41.37-240.288-3.286-2.138-2.228-3.011
Depreciation & Amortization 0.2170.2280.2360.2360.240.2480.2380.2370.0890.0360.0350.0320.0280.0120.0130.0070.0020000
Deferred Income Tax 0.9950.3891.2540.5670.434-0.135-2.89-23.6390-2.857-0.1350000000000
Stock Based Compensation 7.8838.3288.4538.6118.1547.437.5597.2137.196.6177.0275.6035.7184.7594.1333.2292.7310.0910.0290.090.063
Change In Working Capital 025.19911.804-5.888-9.168-3.445-4.446-5.661-5.378-14.0437.066.497-2.345-1.94-0.138-6.9823.683-0.409-0.2450.366-0.209
Accounts Receivables 0-12.0959.84301.209-7.964-2.329-6.1924.345-3.937-2.4980.427-5.6953.481-5.086-3.26-1.8560000
Change In Inventory 0000002.3296.192-9.7233.9372.498-0.427000000000
Change In Accounts Payables -2.0950.1431.706-2.188-4.250.590.083-1.576-1.8152.5963.1321.843-1.224.1570000000
Other Working Capital 037.1510.255-3.7-6.1273.928-4.529-4.0851.815-16.6393.9284.654-1.125-5.4224.947-3.7225.539-0.409-0.2450.366-0.209
Other Non Cash Items 034.385-0.57-0.291.11.9590.7952.6740.9751.8560.8-7.3481.083.09311.89217.745225.7980.3230.459-0.043-0.482
Operating Cash Flow -57.246-42.8-21.389-40.58-37.286-31.101-37.392-44.062-47.838-51.564-39.088-59.877-50.017-56.289-33.32-33.867-12.666-3.281-1.895-1.815-3.639
Investing Activities:
Investments In Property Plant And Equipment 0-0-0.0340-0-0.028-0.043-0.01-0.088-0.652-0.016-0.229-0.24-0.064-0.048-0.037-0.0370000
Acquisitions Net 0000018.247-86.629000000-0.1540.1-0.28663.7740000
Purchases Of Investments -222.3880.573146.834-120.534-19.999-70.24-37.499-71.089-86.248000000000000
Sales Maturities Of Investments 024.41244.99865.12836.76151.98186.62900000000000000
Other Investing Activites 00.588-146.834-0.05316.762-18.24786.248-71.089-86.2480.2060004.5960-0.112-4.4840000
Investing Cash Flow -222.3882544.964-55.45916.762-18.28748.706-71.099-86.336-0.446-0.016-0.229-0.24-0.2170.052-0.32363.7370000
Financing Activities:
Debt Repayment 000000000000073.6380000000
Common Stock Issued 0-0.03242.708107.2729.6556.24314.5640.01200.0950.220.0690.333-0.933-0.776345.425242.7270000
Common Stock Repurchased 00000000000000-0-0.01200000
Dividends Paid 000000000000000000000
Other Financing Activities 3.0862.9933.275-1.9590.8380.1180.180.01200.0890.2240.070.0740.296-0.296345.413241.8891.2850.07700
Financing Cash Flow 3.0862.963245.983105.31310.4936.37814.7440.01200.0890.2240.070.07473.001-1.072345.413242.7271.2850.07700
Other Information:
Effect Of Forex Changes On Cash -1.5173.032-1.904-0.120.219-0.5040.220.3810.5180.722-0.438-0.268-0.434-1.6710.2653.352-0.0440.3550.491-0.06-0.861
Net Change In Cash -278.065-11.805267.6549.154-9.812-43.46826.278-114.768-133.656-51.199-39.318-60.304-50.61716.267-41.202308.889291.385-1.641-1.327-1.875-4.5
Cash At End Of Period 105.156383.221395.026127.372118.218128.03171.498145.22259.988393.644444.843484.161544.465595.082578.815613.759298.6127.2278.86810.19512.07